Ysb Inc.

Ysb Inc. (药师帮) is a Chinese digital pharmaceutical distribution platform built around a business-to-business marketplace that links upstream pharmaceutical manufacturers and distributors with downstream retail pharmacies, private clinics and village health posts. The company was founded in Guangzhou in 2015 and grew out of the wave of 'Internet + healthcare' ventures that sought to digitise China's highly fragmented drug wholesale chain, where hundreds of thousands of small pharmacies and rural clinics had long depended on multi-tier offline distributors. Ysb's core offering is its online pharmaceutical trading marketplace, where verified downstream buyers can search and order medicines, traditional Chinese medicine, medical devices and consumer health products at transparent prices, with logistics and fulfilment handled through a network of warehouses and third-party carriers. Alongside the marketplace, the company has built a suite of digital tools for pharmacy operators — including SaaS-based store management, smart procurement and data analytics — and has expanded into areas such as self-operated (first-party) sales of selected product categories and supply-chain financing services for small pharmacies. The platform's positioning is that of an 'empowering' infrastructure layer for China's long tail of small pharmaceutical retailers: it aims to lower procurement costs, widen product selection and improve supply reliability for outlets that are too small to negotiate directly with manufacturers. This has made Ysb one of the better-known names in China's pharmaceutical B2B e-commerce segment, competing with other digital drug-distribution platforms and with the wholesale arms of large distributors. Ysb is a publicly listed company, with its shares traded on the Hong Kong Stock Exchange under the ticker 9885.HK. Its investor base and disclosure obligations follow Hong Kong listing rules, and its reporting focuses on metrics such as gross merchandise volume, active buyers and take rate on the marketplace. The company remains active and continues to invest in digitalising pharmacy operations and in extending coverage into lower-tier cities and rural areas.

Ysb was founded in Guangzhou in 2015, at a moment when Chinese investors and entrepreneurs were pushing aggressively into 'Internet + healthcare'. China's pharmaceutical retail sector was, and remains, extremely fragmented: hundreds of thousands of individually owned pharmacies and small chains, plus a large number of private clinics and village health posts, bought their stock through layered provincial and municipal distributors. Prices and product availability varied widely, and small buyers had little bargaining power. Ysb's answer was to build an online marketplace where verified pharmacies and clinics could browse products from many suppliers in one place, compare prices and place orders that were then fulfilled through logistics partners. By aggregating demand from the long tail of small buyers, the platform could offer better terms than a single small store could obtain on its own. The model attracted venture funding through the late 2010s as the company expanded its supplier base and geographic coverage beyond its home region. As the marketplace scaled, Ysb extended beyond pure matching. It added self-operated sales for selected categories, built out warehousing and fulfilment capabilities, and developed software tools that let pharmacy owners manage inventory, orders and store operations digitally. It also moved into supply-chain finance, using platform transaction data to help small pharmacies access working capital — a common pain point for independent drugstores in China. A significant milestone came when the company listed its shares on the Hong Kong Stock Exchange, trading under the ticker 9885.HK. The listing gave Ysb access to public capital markets and imposed the disclosure and governance standards of a Hong Kong-listed issuer, including regular reporting of operating metrics such as gross merchandise volume and active buyer numbers. In the years since, Ysb has continued to position itself as a digitalisation partner for grassroots healthcare retail in China, investing in technology, expanding into lower-tier cities and rural counties, and broadening its product categories beyond prescription and over-the-counter medicines into traditional Chinese medicine, devices and consumer health products. The company remains active, operating in a competitive landscape that includes other pharmaceutical B2B platforms and the digital wholesale initiatives of large pharmaceutical distributors.

• 2015

  Founded in Guangzhou as a pharmaceutical B2B e-commerce platform

• Listed on the Hong Kong Stock Exchange under ticker 9885.HK

Digital infrastructure and B2B marketplace empowering China's small pharmacies and grassroots clinics with lower-cost, broader drug procurement.

• Pharmaceutical B2B marketplace

  Online marketplace where verified pharmacies and clinics purchase medicines, TCM, devices and health products from many suppliers.

• Pharmacy SaaS tools

  Digital store management, inventory and procurement software for independent pharmacies.

• Supply-chain finance

  Working-capital solutions for small pharmacies based on platform transaction data.

1. 1药师帮官方网站ysbang.cn